Abstract
In this issue of Nature Neuroscience, Golden et al. unveil a mouse model that enables in vivo ‘switching’ from the Alzheimer’s risk gene APOE4 to the protective gene APOE2. This genetic conversion reshapes Alzheimer’s disease-related metabolism, reduces neuropathology, and enhances cognition, demonstrating the beneficial effects of APOE genetic targeting as a promising therapeutic strategy.
| Original language | English |
|---|---|
| Pages (from-to) | 2407-2409 |
| Journal | Nature Neuroscience |
| DOIs |
|
| Publication status | Published - 11 Nov 2025 |
Bibliographical note
Publisher Copyright:© Springer Nature America, Inc. 2025.
Fingerprint
Dive into the research topics of 'Flipping APOE to reverse Alzheimer’s disease traits'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver